Evidence map›Paper›PMID 38173472›Full record

ArticleHeliyon2024

Evaluation the cytotoxic effect of Fe

Tabarek Abdulrazaq Alkinani, Fahimeh Abedini Bajgiran, Mohammad Rezaei, Ali Motamedi Maivan, Fatemeh Jafari Golrokh, Mona Bejarbaneh, Sara Rezaei Mojdehi, Sahar Gorji, Reza Ghasemian, Mohammad Dashtban Jalil Pustin Sarai and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Tabarek Abdulrazaq AlkinaniCollege of Pharmacy, Al-zahraa University for Women, Iraq.
Fahimeh Abedini BajgiranDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Mohammad RezaeiIranian Research Organization for Science and Technology, Tehran, Iran.
Ali Motamedi MaivanDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Fatemeh Jafari GolrokhDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Mona BejarbanehDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Sara Rezaei MojdehiDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Sahar GorjiDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Reza GhasemianDepartment of Medical Sciences, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Mohammad Dashtban Jalil Pustin SaraiDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Fatemeh AkbariDepartment of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Somayeh DehghanDepartment of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Fatemeh MirzaeeDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Noor Hussein AbdulrahmanCollege of Pharmacy, Al-zahraa University for Women, Iraq.
Ali SalehzadehDepartment of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.
Islamic Azad University Rasht Branch · IRAl-Zahraa University for WomenIranian Research Organization for Science and Technology · IRIslamic Azad University Central Tehran Branch · IRIslamic Azad University Medical Branch of Tehran · IRIslamic Azad University of Shahrekord · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of nanotechnology products with supermagnetic properties for targeted delivery of drugs has gained attention recently. Due to the anticancer features of Gingerol, the major phenolic compound from Ginger, this study aims to prepare Fe

Indexed as

ApoptosisGingerolLung cancerMagnetic nanoparticles

Identifiers

PMID38173472
PMCPMC10761571
OpenAlexW4389513906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.